Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017036255) MOLECULAR CONSTRUCTS FOR PREVENTING THE FORMATION OF BLOOD CLOT AND/OR TREATING THROMBOSIS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2017/036255 International Application No.: PCT/CN2016/090296
Publication Date: 09.03.2017 International Filing Date: 18.07.2016
IPC:
C07K 19/00 (2006.01) ,A61P 7/02 (2006.01) ,C07K 16/18 (2006.01) ,A61K 39/44 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
19
Hybrid peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7
Drugs for disorders of the blood or the extracellular fluid
02
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
44
Antibodies bound to carriers
Applicants:
IMMUNWORK INC. [CN/CN]; 1F, No. 47, Sec. 2, Academia Rd., Nangang Dist. Taipei City 115, Taiwan, CN
Inventors:
CHANG, Tse-Wen; CN
CHU, Hsing-Mao; CN
LIN, Chun-Yu; CN
TIAN, Wei-Ting; CN
Agent:
CHINA ZHENGHE INTELLECTUAL PROPERTY AGENCY; Unit C7, Floor 17, Block 2, Xihuan Plaza No. 1 Xizhimenwai Street, Xicheng District, Beijing 100044, CN
Priority Data:
62/213,01201.09.2015US
62/308,34915.03.2016US
PCT/CN2016/07118418.01.2016CN
Title (EN) MOLECULAR CONSTRUCTS FOR PREVENTING THE FORMATION OF BLOOD CLOT AND/OR TREATING THROMBOSIS
(FR) CONSTRUCTIONS MOLÉCULAIRES DESTINÉES À PRÉVENIR LA FORMATION D’UN CAILLOT SANGUIN ET/OU À TRAITER LA THROMBOSE
Abstract:
(EN) The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
(FR) La présente invention concerne différentes constructions moléculaires comprenant un élément de ciblage et un élément effecteur. L'invention concerne également des méthodes de traitement de diverses maladies à l'aide de ces constructions moléculaires.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)